lncRNA MEG8 small interfering RNA (siRNA), negative control (NC) siRNA and
miR-203 inhibitor were purchased from Shanghai GenePharma Co., Ltd. The sequences for
lncRNA MEG8 siRNA,
NC siRNA, miR-203 inhibitor and NC inhibitor were as follows: lncRNA MEG8 sense, 5′GGCCAGCUGAUUUAAUAAUUU3′, lncRNA MEG8 antisense, 5′AUUAUUAAAUCAGCUGGCCUU3′;
NC siRNA sense, 5′GAAUUAAUUAAAGAUGGCCCGUUGUAC3′,
NC siRNA antisense, 5′UCAUCGAAGUUAUAGGGAUACAUUACGUGAUC3′; miR-203 inhibitor, 5′CUAGUGGUCCUAAACAUUUCAC3′; NC inhibitor, 5′CAGUACUUUUGUGUAGUACAA3′. A total of 2×10
5 HemECs were seeded into 6-well plates 24 h prior to transfection. Following incubation, the HemECs were transfected with 50 pM
NC siRNA, 50 pM
lncRNA MEG8 siRNA, 50 pM NC inhibitor, 50 pM
miR-203 inhibitor or 50 pM
lncRNA MEG8 siRNA + 50 pM
miR-203 inhibitor using Lipofectamine
® 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.) for 6 h at 37°C, according to the manufacturer's protocol. Untransfected HemECs were used as the control.
Hu Z., Liu X., Guo J., Zhuo L., Chen Y, & Yuan H. (2021). Knockdown of lncRNA MEG8 inhibits cell proliferation and invasion, but promotes cell apoptosis in hemangioma, via miR-203-induced mediation of the Notch signaling pathway. Molecular Medicine Reports, 24(6), 872.